Advancements in long non-coding RNA-based therapies for cancer: targeting, delivery, and clinical implications

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Long non-coding RNAs (lncRNAs) regulate vital cellular processes like development and differentiation.
• Their role in cancer prevention is under-explored, despite potential therapeutic applications.
• lncRNAs offer unique secondary structures and sequence motifs as targets for novel therapies.

Purpose of the Study:

• To review current lncRNA biology and mechanisms of action.
• To explore nanoformulation strategies for lncRNA delivery.
• To examine clinical trials involving lncRNA delivery systems for disease treatment.

Main Methods:

• Literature review of lncRNA research.
• Analysis of lncRNA targeting strategies (small molecules, antisense oligonucleotides).
• Examination of advancements in drug delivery systems and nucleotide modification.

Main Results:

• lncRNAs are implicated in various human pathologies.
• Targeting lncRNAs shows promise for disease prevention and treatment.
• Challenges remain in developing specific and effective delivery vehicles for lncRNA therapies.
• Recent advances improve drug stability and reduce immunogenicity, but further progress is needed.

Conclusions:

• lncRNA-based therapies hold significant potential for treating complex diseases like cancer.
• Further research into optimized delivery systems is crucial for clinical translation.
• Continued exploration of lncRNA biology and therapeutic strategies is warranted.